Correction: Cancer and treatment specific incidence rates of immune-related adverse events induced by immune checkpoint inhibitors: a systematic review

Bishma Jayathilaka^{1

2

3}, Farah Mian⁴, Fanny Franchini⁵, George Au-Yeung^{6

7}, Maarten IJzerman^{6

5

8}

Affiliations

¹ Pharmacy Department, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia. bishma.jayathilaka@unimelb.edu.au.
² Sir Peter MacCallum Department of Oncology, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Melbourne, VIC, Australia. bishma.jayathilaka@unimelb.edu.au.
³ Cancer Health Services Research Unit, Centre for Cancer Research, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Melbourne, VIC, Australia. bishma.jayathilaka@unimelb.edu.au.
⁴ Pharmacy Department, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.
⁵ Cancer Health Services Research Unit, Centre for Cancer Research, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Melbourne, VIC, Australia.
⁶ Sir Peter MacCallum Department of Oncology, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Melbourne, VIC, Australia.
⁷ Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.
⁸ Erasmus School of Health Policy & Management, Erasmus University, Rotterdam, The Netherlands.

Published Erratum

Bishma Jayathilaka et al. Br J Cancer. 2025 Jan.

. 2025 Jan;132(1):137.

doi: 10.1038/s41416-024-02920-3.

Bishma Jayathilaka^{1

2

3}, Farah Mian⁴, Fanny Franchini⁵, George Au-Yeung^{6

7}, Maarten IJzerman^{6

5

8}

¹ Pharmacy Department, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia. bishma.jayathilaka@unimelb.edu.au.
² Sir Peter MacCallum Department of Oncology, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Melbourne, VIC, Australia. bishma.jayathilaka@unimelb.edu.au.
³ Cancer Health Services Research Unit, Centre for Cancer Research, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Melbourne, VIC, Australia. bishma.jayathilaka@unimelb.edu.au.
⁴ Pharmacy Department, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.
⁵ Cancer Health Services Research Unit, Centre for Cancer Research, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Melbourne, VIC, Australia.
⁶ Sir Peter MacCallum Department of Oncology, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Melbourne, VIC, Australia.
⁷ Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.
⁸ Erasmus School of Health Policy & Management, Erasmus University, Rotterdam, The Netherlands.

No abstract available

Erratum for

Cancer and treatment specific incidence rates of immune-related adverse events induced by immune checkpoint inhibitors: a systematic review.
Jayathilaka B, Mian F, Franchini F, Au-Yeung G, IJzerman M. Jayathilaka B, et al. Br J Cancer. 2025 Jan;132(1):51-57. doi: 10.1038/s41416-024-02887-1. Epub 2024 Nov 3. Br J Cancer. 2025. PMID: 39489880 Free PMC article.